ADVERTISEMENT

Home|Journals|Articles by Year|Audio Abstracts
 

Original Article

AJVS. 2025; 87(0): 259-272


The Antifertility Effects of Gossypol–Bovine Serum Albumin Nanoparticles and its Hepatorenal Impact in Male Rats

Reham Waheeb, Samah S. Oda, Hoda Elkhenany, Mayada Marouf, Alshimaa A. Abd-Elmoneam, Mahmoud M. Elmaghraby.



Abstract
Download PDF Post

The current study aimed at evaluating the efficacy of gossypol–bovine serum albumin nanoparticles (Gossy-BSA NPs) as an antifertility compound and to assess its effect on hepatorenal function in rats. For this purpose, eighteen adult male albino rats were allocated into 2 groups: treated rats (n=9), received single bilateral intra-testicular injection of 2mg Gossy-BSA NPs, and control rats (n=9), received normal saline by the same route. Quality of epididymal semen, selected biochemical parameters, testosterone level and the histopathology of testes, epididymis, liver and kidney were estimated at 2-, 4-, and 6-weeks following treatment. Gossy-BSA NPs treatment induced deteriorated semen quality related parameters evidenced by a significant (P < 0.01) reduction in sperm count, motility, and also reduced serum level of testosterone. Serum alanine aminotransferase (ALT) significantly elevated (P < 0.05) at weeks 2 and 6 in treated rats relative to controls. Other parameters such as albumin, bilirubin, urea, creatinine, and CRP showed normal values in treated rats. Histopathological analysis revealed progressive degeneration in seminiferous epithelium and loss of germ cells over the experiment duration. Liver and kidney showed mild to moderate inflammatory changes involving congestion and inflammatory cells infiltration. These findings indicate that Gossy-BSA NPs has antifertility properties with tolerable systemic effects, however further studies are needed to assess their long-term safety and efficacy.

Key words: Gossypol nanoparticles, antifertility, hepatorenal effects, testosterone, semen quality, histopathology.







Bibliomed Article Statistics

36
28
19
14
R
E
A
D
S

40

35

35

13
D
O
W
N
L
O
A
D
S
11120102
20252026

Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Author Tools
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.